Quarterly Result6 Nov 2025, 01:16 pm
Zydus Lifesciences Announces Q2 & H1 FY26 Financial Results: Revenue Up 17% & 11% Respectively
AI Summary
Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and half year ended September 30, 2025. The company reported a 17% YoY increase in revenue from operations for Q2 FY26, standing at Rs. 61,232 mn. For H1 FY26, the revenue from operations was up by 11% YoY, reaching Rs. 126,969 mn. The EBITDA for Q2 FY26 was Rs. 20,158 mn, a 38% YoY increase, with an EBITDA margin of 32.9%. The net profit for the quarter was Rs. 12,586 mn, a 38% YoY growth. The net debt to equity ratio as on 30 September, 2025 was 0.09x, and net debt to EBITDA stood at 0.3x at the end of September, 2025.
Key Highlights
- Revenue from operations for Q2 FY26 at Rs. 61,232 mn, up 17% over last year
- EBITDA for Q2 FY26 at Rs. 20,158 mn, up 38% YoY
- EBITDA margin for Q2 FY26 at 32.9%, an improvement of 500 bps on a YoY basis
- Net Profit for Q2 FY26 at Rs. 12,586 mn, up 38% YoY
- Net Debt to Equity ratio as on 30 September, 2025 at 0.09x and Net Debt to EBITDA at 0.3x